Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabio.scirocchi@uniroma1.it
Fabio Scirocchi
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
fabio.scirocchi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
JOURNAL OF TRANSLATIONAL MEDICINE
2024
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
IMMUNITY
2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature
CANCERS
2024
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients
FRONTIERS IN IMMUNOLOGY
2024
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma
www.siica.it
2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs
JOURNAL OF TRANSLATIONAL MEDICINE
2023
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients
AICC INTERNATIONAL MEETING – TRANSLATIONAL AND PRECISION MEDICINE
2023
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients
CLINICAL CANCER RESEARCH
2022
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response
EBIOMEDICINE
2022
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: Systematic review and Meta-Analysis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients
ANNALS OF ONCOLOGY
2022
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study
JOURNAL OF PERSONALIZED MEDICINE
2021
Immunogenic cell death and immunomodulatory effects of cabozantinib
FRONTIERS IN ONCOLOGY
2021
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
JOURNAL OF PERSONALIZED MEDICINE
2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
JOURNAL OF PERSONALIZED MEDICINE
2020
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma